Fetal laboratory medicine: On the frontier of maternal-fetal medicine

Clinical Chemistry

Volumn 58, Issue 2, 2012, Pages 337-352

  Geaghan, Sharon M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; BLOOD ANALYSIS; CHORION VILLUS SAMPLING; CORDOCENTESIS; DIAGNOSTIC PROCEDURE; FETOPLACENTAL UNIT; FETOSCOPY; FETUS; FETUS BLOOD SAMPLING; FETUS SURGERY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MECONIUM; MINIMALLY INVASIVE SURGERY; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; TECHNOLOGY;

ANEUPLOIDY; CLINICAL LABORATORY TECHNIQUES; CORDOCENTESIS; DNA; FEMALE; FETAL DISEASES; FETOSCOPY; GENETIC TESTING; HUMANS; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; REFERENCE VALUES;

EID: 84856386945     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.166991     Document Type: Review

References (95)

1. Harrison MR, Filly RA, Parer JT, Faer MJ, Jacobsen JB, de Lorimier AA. Management of the fetus with a urinary tract malformation. JAMA 1981; 246:635-9. (Pubitemid 12197201)
2. Crombleholme TM, Harrison MR, Longaker MT, Langer JC. Prenatal diagnosis and management of bilateral hydronephrosis. Pediatr Nephrol 1988;2:334-42.
3. Deprest JA, Flake AW, Gratacos E, Ville Y, Hecher K, Nicolaides K, et al. The making of fetal surgery. Prenat Diagn 2010;30:653-67.
4. Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, et al. The MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011;364:993-1004.
5. Quintero RA, Bornick PW, Morales WJ, Allen MH. Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation. Am J Obstet Gynecol 2001;185:689-96. (Pubitemid 32862560)
6. Leviton LC, Goldenberg RL, Baker CS, Schwartz RM, Freda MC, Fish LJ. Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial. JAMA 1999;281:46-52. (Pubitemid 29025099)
7. Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases. Am J Obstet Gynecol 1983;146:985-7. (Pubitemid 13037282)
8. Duhamel F, Oury JF, Mennesson B, Muray JM. Complications of diagnostic ultrasound-guided percutaneous umbilical blood sampling: analysis of a series of 341 cases and review of the literature. Eur J Obstet Gynecol Reprod Biol 1993;52: 95-104.
9. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153:655- 60.
10. Nicolaides KH, Soothill PW, Rodeck CH, Clewell W. Rh disease: intravascular fetal blood transfusion by cordocentesis. Fetal Ther 1986;1:185-92. (Pubitemid 17136906)
11. Nicolaides KH, Clewell WH, Rodeck CH. Measurement of human placental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol 1987; 157:50 -3.
12. Rizzo G, Nicolaides KH, Arguing D, Campbell S. Effects of intravascular fetal blood transfusion on fetal intracranial Doppler velocity waveforms. Am J Obstet Gynecol 1990;163:1231-8. (Pubitemid 20377407)
13. Geaghan S. Fetal reference intervals: biochemical parameters: reference interval corner. The Monitor: the newsletter of the Pediatric and Maternal-Fetal Division of the AACC. AACC. 2011:20;2-3. http://www.aacc. org/ SiteCollectionDocuments/Master%20Newsletter/Pediatric%20Maternal%20Fetal- %20Newsletter- Archives/PMF-Newsletter-vol30no2.pdf (Accessed December 2011).
14. Podratz R, Broughton DD, Gustafson DH Bergstralh EJ, Melton JL. Weight loss and body temperature changes in breast-fed and bottle-fed neonates. Clin Pediatr 1986:25;73-7. (Pubitemid 16177496)
15. Shaffer SG, Quimiro CL, Anderson JV, Hall RT. Postnatal weight changes in low birth weight infants. Pediatrics 1987:79;702-5. (Pubitemid 17087134)
16. Lorenz, JM. Assessing fluid and electrolyte status in the newborn. Clin Chem 1997;43:205-10. (Pubitemid 27024417)
17. Horowitz G, Boyd JC, Ceriotti F, Garg U, Altaie S, Pesce A, et al. Establishing and verifying reference intervals in the clinical laboratory; proposed guideline.3rd ed. CLSI document C28-P3. Wayne (PA): CLSI; 2008. p 1-49.
18. Royston P, Wright EM. How to construct "normal ranges" for fetal variables. Ultrasound Obstet Gynecol 1998;11:30-8. (Pubitemid 28097444)
19. Chen C, David BH, Wood B, Warzynski MJ. Mul ticenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002;50:285-90. (Pubitemid 37509503)
20. College of American Pathologists. College of American Pathologists proficiency survey HFB 2011-A. Waukegan (IL): College of American Pathologists; 2011.
21. Raeihae NC. Organic acids in fetal blood and amniotic fluid. Pediatrics 1963;32:1025-32.
22. Gozzo ML, Noia G, Barbaresi G, Colacicco L, Serraino MA, De Santis M, et al. Reference intervals for 18 clinical chemistry analytes in fetal plasma samples between 18 and 40 weeks of pregnancy. Clin Chem 1998;44:683-5. (Pubitemid 28141378)
23. Weiner CP, Sipes SL, Wenstrom K. The effect of fetal age upon normal fetal laboratory values and venous pressure. Obstet Gynecol 1992;79:713- 8.
24. Orlandi F, Damiani G, Jakll C, Rossi C, Maggio A, Scola B, et al. Clinical results and fetal biochemical data in 140 early second trimester diagnostic cordocenteses. Acta Eur Fertil 1987;18:329 -33.
25. Legras B, Clerc C, Rueland A, Vialard J, Millon J, Cloarec L. Blood chemistry of human fetuses in the second and third trimesters. Prenatal Diag 1990;10:801-7.
26. Forestier F, Daffos F, Rainaut M, Bruneau M, Trivin F. Blood chemistry of normal human fetuses at midtrimester of pregnancy. Pediatr Res 1987;21:579-83. (Pubitemid 17076191)
27. Berrebi A, Benichou AC, Sarramon MF, Bessieres MH, Rolland M, Kobuch WE, et al. Valeurs biologiques de reference chez le foetus humain: a propos de 108 ponctions de cordon in utero. J Gynecol Obstet Biol Reprod 1992;21:355-9.
28. Gitlin D. Development and metabolism of the immune globulins. In: Kaga BM, Stiehm ER, eds. Immunologic incompetence. Chicago: Year Book Medical Publishers; 1971. p 396.
29. Pardi G, Buscaglia M, Ferrazzi E, Bozzetti P, Marconi AM, Cetin I, et al. Cord sampling for the evaluation of oxygenation and acid-base balance in growth-retarded human fetuses. Am J Obstet Gynecol 1987;157:1221-8. (Pubitemid 17163805)
30. Soothill PW, Ajayi RA, Campbell S, Ross EM, Cabndy DC, Snijders RM et al. Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment. Ultrasound Obstet Gynecol 1992;2:80-3.
31. East CE, Leader LR, Sheehan P, Henshall NE, Colditz PB. Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace. Cochrane Database Syst Rev 2010;17:CD006174.
32. Stout MJ, Cahill MG. Electronic fetal monitoring: past, present, and future. Clin Perinatol. 2011;38: 127-42, vii.
33. Bokenkamp A, Dieterich C, Dressler F, Mulhaus K, Gembruch U, Bald R, et al. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 2001;185:468-75. (Pubitemid 32769453)
34. Morris RK, Quinlan-Jones E, Kilby MD, Khan KS. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat Diagn 2007;27:900 -11.
35. Morris RK, Malin GL, Khan KS, Kilby MD. Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy. BJOG 2009; 116:1290 -9.
36. Morris RK, Ruano R, Kilby MD. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review. Ultrasound Obstet Gynecol 2011;37:629 -37.
37. Ghizzoni L, Cesari S, Cremonini G, Melandri L. Prenatal and early postnatal treatment of congenital adrenal hyperplasia. Endocr Dev 2007;11: 58-69.
38. Sulcova J, Macek M, Chudoba D, Hubi W, Hill M, Starka. L. Amniotic fluid 17-hydroxyprogesterone in early pregnancy. J Steroid Biochem Mol Biol. 1994;51:315- 8.
39. Greaves RF, Hunt RW, Chiriano AS, Zacharin MR. Luteinizing hormone and follicle-stimulating hormone levels in extreme prematurity: development of reference intervals. Pediatrics 2008;21:e574-80.
40. Geaghan S. Hematologic values and appearances in the healthy fetus, neonate and child. Clin Lab Med 1999;19:1-37. (Pubitemid 29217316)
41. Millar DS, Davis LR, Rodeck CH, Nicolaides KH, Mibashan RS. Normal blood cell values in the early mid-trimester fetus. Prenatal Diag 1985;5: 367-73. (Pubitemid 16154864)
42. Forestier F, Daffos F, Catherine N, Renard M, Andreux JP. Developmental hematopoiesis in normal human fetal blood. Blood 1991;77:2360 -3.
43. Daffos F, Forestier F, Kaplan C, Cox W. Prenatal diagnosis and management of bleeding disorders with fetal blood sampling. Am J Obstet Gynecol 1988;158:939-46.
44. Rabinowitz R, Peters MT, Vyas S, Campbell S, Nicolaides KH. Measurement of fetal urine production in normal pregnancy by real-time ultrasonography. Am J Obstet Gynecol 1989;161: 1264-6. (Pubitemid 20007695)
45. Burc L, Guibourdenche J, Luton D, Noel M, Beaudeux J, De Lagausie P, et al. Establishment of reference values of five amniotic fluid enzymes: analytical performances of the Hitachi 911 Application to complicated pregnancies. Clin Biochem 2001;34:317-22. (Pubitemid 32607575)
46. Bevis DC. Composition of liquor amnii in haemolytic disease of the newborn. J Obstet Gynaecol Br Emp 1953;60:244-51.
47. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 1961;82: 1359-70.
48. Queenan JT, Tomai TP, Ural SH, King JC. Deviation in amniotic fluid optical density at a wave-length of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol 1993; 168:1370-6. (Pubitemid 23153274)
49. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14. (Pubitemid 30020654)
50. Sloan R, Archibold GP, Lloyd F, Elliott RJ. Glycoaminoglycan accumulation in amniotic fluid during early pregnancy. Biochem Soc Trans 1996; 24:103S. (Pubitemid 26052356)
51. Gareri J, Klein J, Koren G. Drugs of abuse testing in meconium. Clin Chim Acta 2006;366:101-11. (Pubitemid 43330971)
52. Gourley GR, Kreamer B, Arend R. Excremental studies in human neonates. Identification of zinc coproporphyrin as a marker for meconium. Gastroenterology 1990;99:1705-9.
53. Verma A, Dhanireddy R. Time of first stool in extremely low birth weight (< or = 1000 grams) infants. J Pediatr 1993;122:626-9. (Pubitemid 23093594)
54. Koren G, Hutson J, Gareri J. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther 2008;83: 631-4. (Pubitemid 351417069)
55. Chan D, Caprara D, Blanchette P, Klein J, Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem 2004;37:429 -38.
56. Cernichiari E, Myers GJ, Ballatori N, Zareba G, Vyas J, Clarkson T. The biological monitoring of prenatal exposure to methyl mercury. Neurotoxicology 2007;28:1015-22. (Pubitemid 47519795)
57. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 2007;388:1455- 65.
58. Burton BK. Elevated maternal serum alphafetoprotein (MSAFP): interpretation and followup. Clin Obstet Gynecol 1988;31:293.
59. Roberts NS, Dunn LK, Weiner S. Midtrimester amniocentesis: indications, technique, risk and potential for prenatal diagnosis. J Reprod Med 1983;28:167.
60. Brumfeld CG, Cloud GA, Davis RO. The relationship between maternal serum and amniotic fluid α-fetoprotein in women undergoing early amniocentesis. Am J Obstet Gynecol 1990;163:903.
61. Loew MP, Zimmerman B, Hansen W. Prospective randomized controlled trial of fetal fibronection on preterm labor management in a tertiary care center. Am J Obstet Gynecol 2004;190:358-62. (Pubitemid 38249229)
62. Swamy G, Simhan HN, Gammill HS, Heine RP. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 2005;50:851-6. (Pubitemid 41720973)
63. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010;116:393- 401.
64. Ashwood ER. Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem 1997;43: 211-4. (Pubitemid 27024418)
65. Cousins LM, Smok DP, Lovett SM, Poeltler DM. Amnisure placental α-microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol 2005;22:317-20. (Pubitemid 41266013)
66. Kingdom JCP, Bajoria R. Fetal assessment and management of labor in twin pregnancy. Adv Obstet Gynaecol 1998;20: 65-80.
67. Bajoria R, Lazda EJ, Ward S, Sooranna SR. Iron metabolism in monochorionic twin pregnancies in relation to twin-twin transfusion syndrome. Hum Reprod 2001;16:567-73. (Pubitemid 32218811)
68. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal screening for aneuploidy. Obstet Gynecol 2007;110:1459-67.
69. Borgida AF, Mills AA, Feldman DM, Rodis JF, Egan JF. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol 2000;183:937-9.
70. Botto LD, Olney RS, Matroiacovo P, Khoury MJ, Moore CA, Alo CJ, et al. Chorionic villus sampling and transverse digital deficiencies: evidence for anatomic and gestational-age specificity of the digital deficiencies in two studies. Am J Med Genet 1996;62:173-8.
71. Brambati B, Tului L. Prenatal genetic diagnosis through chorionic villus sampling. In: Milunsky A, Milunsky JM, eds. Genetic disorders and the fetus: diagnosis, prevention, and treatment, 5th ed. Baltimore (MD): John Hopkins University Press; 2004. p 179-213.
72. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol 2009;114:1161-3.
73. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105: 16266-71.
74. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105: 20458-63.
75. Chiu RW, Sun H, Akolekar R, Clouser C, Lee C, McKernan K, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010;56:459-63.
76. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75. (Pubitemid 28194317)
77. Li Y, Zimmerman B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNAs in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004;50: 1002-11. (Pubitemid 38725787)
78. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92. (Pubitemid 38125703)
79. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Analysis of the size distribution of fetal and maternal cell-free DNA by paired-end sequencing. Clin Chem 2010;56:1279-86.
80. Lun MF, Tsui ABY, Chan KCA, Leung TY, Lau TK, Charoenkwan P, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A 2008; 105:19920-5.
81. Hahn T, Drese KS, O'Sullivan CK. Microsystem for isolation of fetal DNA from maternal plasma by preparative size separation. Clin Chem 2009;55: 2144-52.
82. Jorgez CJ, Bischoff FZ. Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification. Fetal Diagn Ther 2009;25:314-9.
83. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2: 61ra91.
84. Fan HC, Blumenfeld YJ, El-Sayed YY, Chueh J, Quake SR. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am J Obstet Gynecol 2009;200:543.e1-7.
85. Chui RW, Akolelar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
86. Liao GJ, Lun FM, Zheng YW, Chan KC, Leung TY, Lau TK, et al. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 2011;57:92-101.
87. Avent ND. RHD genotyping from maternal plasma: guidelines and technical challenges. Methods Mol Biol 2008;444:185-201.
88. Tynan JA, Angkachatchai V, Ehrich M, Paladino T, van den Boom D, Oeth P. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 2011;204:251.e1-6.
89. Wright C, Quake SR, Bianchi D, Wald NJ. Community Corner: opening the Pandora's box of prenatal genetic testing. Nat Med 2011;17: 250-1.
90. Schmitz D, Henn W, Netzer C. Commentary: no risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing. BMJ 2009;339: b2690.
91. George SM. Millions of missing girls: from fetal sexing to high technology sex selection in India. Prenat Diagn 2006;26:604-9. (Pubitemid 44149780)
92. Lai-wan CC, Blyth E, Hoi-yan CC. Attitudes to and practices regarding sex selection in China. Prenat Diagn 2006;26:610-3. (Pubitemid 44146774)
93. Bodurtha J, Strauss JF. Genomics and perinatal care. N Engl J Med 2012:366:64-73.
94. Hosper NA, Eggink AJ, Roelofs LA, Wijnen RM, van Luyn MJ, Bank RA, et al. Intra-uterine tissue engineering of full-thickness skin defects in a fetal sheep model. Biomaterials 2010;31: 3910-9.
95. Geaghan S. Fetal health assessment in utero by laboratory technologies: clinical benefits, risks and controversies. Clin Biochem 2011;44: 460-2.